Drug and Medication Analysis & Statistics, January 2013 (p30)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: drug, vaccine, smoking cessation, more »

871-910 of about 4 000 reports

Purchase Reports From Reputable Market Research Publishers

Hormone Antagonists -Pipeline Insights, 2014

Hormone Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hormone Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2014

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Interferon Receptor Binders -Pipeline Insights, 2014

Interferon Receptor Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interferon Receptor Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Lipase Inhibitors -Pipeline Insights, 2014

Lipase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Lipase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
L-Type Calcium Channel Blockers -Pipeline Insights, 2014

L-Type Calcium Channel Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“L-Type Calcium Channel Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists -Pipeline Insights, 2014

Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug and Medication
Melatonin Receptor Agonists -Pipeline Insights, 2014

Melatonin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Melatonin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Mineralocorticoid Receptor (MR) Antagonists -Pipeline Insights, 2014

Mineralocorticoid Receptor (MR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mineralocorticoid Receptor (MR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors -Pipeline Insights, 2014

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors -Pipeline Insights, 2014

Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Monoamine Oxidase Inhibitors (MAOIs) -Pipeline Insights, 2014

Monoamine Oxidase Inhibitors (MAOIs) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Monoamine Oxidase Inhibitors (MAOIs)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
MT-1 Melatonin Receptor Agonists -Pipeline Insights, 2014

MT-1 Melatonin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“MT-1 Melatonin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2014

MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“MT-2 Melatonin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Nicotinic Agonists -Pipeline Insights, 2014

Nicotinic Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Nicotinic Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Norepinephrine-Dopamine Reuptake Inhibitors (NDRI) -Pipeline Insights, 2014

Norepinephrine-Dopamine Reuptake Inhibitors (NDRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Norepinephrine-Dopamine Reuptake Inhibitors (NDRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug and Medication
Opioid Receptor Agonist -Pipeline Insights, 2014

Opioid Receptor Agonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Opioid Receptor Agonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Opioid Receptor Antagonists -Pipeline Insights, 2014

Opioid Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Opioid Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Parathyroid Hormone Receptor Agonist -Pipeline Insights, 2014

Parathyroid Hormone Receptor Agonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Parathyroid Hormone Receptor Agonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Penicillin-Binding Proteins (PBPs) Inhibitors -Pipeline Insights, 2014

Penicillin-Binding Proteins (PBPs) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Penicillin-Binding Proteins (PBPs) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Poly Adenosine Diphosphate (ADP) Ribose Polymerase (PARP) Inhibitors -Pipeline Insights, 2014

Poly Adenosine Diphosphate (ADP) Ribose Polymerase (PARP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Poly Adenosine Diphosphate (ADP) Ribose Polymerase (PARP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Progesterone Receptor (PR) Antagonists -Pipeline Insights, 2014

Progesterone Receptor (PR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Progesterone Receptor (PR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Progesterone Receptor Agonists -Pipeline Insights, 2014

Progesterone Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Progesterone Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug and Medication
Selective Glucocorticoid Receptor Agonists -Pipeline Insights, 2014

Selective Glucocorticoid Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective Glucocorticoid Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Selective Serotonin Reuptake Inhibitors (SSRI) -Pipeline Insights, 2014

Selective Serotonin Reuptake Inhibitors (SSRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective Serotonin Reuptake Inhibitors (SSRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Serotonin (5-HT) Receptor Agonists -Pipeline Insights, 2014

Serotonin (5-HT) Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin (5-HT) Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Serotonin (5-HT) Receptor Antagonists -Pipeline Insights, 2014

Serotonin (5-HT) Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin (5-HT) Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Serotonin Reuptake Inhibitors (SRI) -Pipeline Insights, 2014

Serotonin Reuptake Inhibitors (SRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin Reuptake Inhibitors (SRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Serotonin Transporter Inhibitors -Pipeline Insights, 2014

Serotonin Transporter Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin Transporter Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Serotonin-Norepinephrine Reuptake Inhibitors(SNRI) -Pipeline Insights, 2014

Serotonin-Norepinephrine Reuptake Inhibitors(SNRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin-Norepinephrine Reuptake Inhibitors(SNRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug and Medication
Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors(SNDRI) -Pipeline Insights, 2014

Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors(SNDRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors(SNDRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug and Medication
About 15 000 reports

Download Unlimited Documents from Trusted Public Sources

Medication Market

  • Cardiovascular Medication Use in Patients with Undiagnosed Obstr...
  • October 2014
    7 pages
  • Medication  

View report >

64 Companies

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.